Work

Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7142

Authors: Yuxuan Che, Ruolan Zeng, Dabei Tang, Ou Bai, Youchao Jia, Yuhuan Gao, Xiaojing Yan, Xiaolei Ding, Xiuli Sun, Xiaobo Wang, Bing Xu, Hui-Han Wang, Dongxia Qu, Liye Xu, Na Li, Qingyuan Zhang, Hui Zhou, Xiuhua Sun

Institutions: Dalian Medical University, Second Affiliated Hospital of Dalian Medical University, Hunan Cancer Hospital, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, First Hospital of Jilin University, Affiliated Hospital of Hebei University, Hebei Medical University, Fourth Hospital of Hebei Medical University, First Hospital of China Medical University, First Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Xiamen University, China Medical University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417006904

Cites:

Cited by:

Related to: